SCHEMBL77944

SCHEMBL77944

COc1cccc(C(=O)C(NC(=O)c2cccc(C)c2C)C(C)(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.45
▸ NPC1 O15118 4/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ TP53 P04637 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ HSP90AA1 P07900 1/20 0.45
▸ HSP90AB1 P08238 1/20 0.45
▸ KCNK3 O14649 2/20 0.44
▸ KCNK9 Q9NPC2 2/20 0.44
▸ TAS1R3 Q7RTX0 1/20 0.44
▸ TAS1R1 Q7RTX1 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ CES2 O00748 1/20 0.43
▸ CES1 P23141 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10227844 0.90 NPC1 (0.48) RAB9ANPC1SMN1; SMN2TP53KDM4E
SCHEMBL76595 0.86 KCNK3 (0.50) RAB9ANPC1SMN1; SMN2KCNK3KCNK9
SCHEMBL76387 0.84 KCNK3 (0.47) RAB9ANPC1SMN1; SMN2TP53TSHR
SCHEMBL76896 0.82 NPC1 (0.45) RAB9ANPC1SMN1; SMN2TP53KCNK3
SCHEMBL10227845 0.80 KCNK3 (0.54) RAB9ANPC1KDM4EKCNK3KCNK9
SCHEMBL10227846 0.76 ABCB1 (0.59) RAB9ANPC1KMT2AKCNK3KCNK9
SCHEMBL25607328 0.70 NPC1 (0.51) RAB9ANPC1TP53TSHRMEN1
SCHEMBL5062430 0.69 ABCB1 (0.65) —
SCHEMBL20090393 0.68 CES2 (0.65) RAB9ANPC1SMN1; SMN2TSHRMEN1
SCHEMBL16857261 0.68 GPR139 (0.59) RAB9ANPC1SMN1; SMN2TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129355-B2 Nuclear receptor-based inducible gene expression system; modulating the expression of a gene in a host cell by introducing into the host cell a gene expression modulation system and activating that system using 5-ethyl-2,3-dihydro-benzo[1,4]dioxine-6-carboxylic acid (1-benzoyl-cyclopentyl)-amide INTREXON CORPORATION (US) 2012-03-06 — — US disclosed
Send feedback